» Articles » PMID: 29942138

MALAT1 Silencing Suppresses Prostate Cancer Progression by Upregulating MiR-1 and Downregulating KRAS

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2018 Jun 27
PMID 29942138
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prostate cancer (PC) is the second leading cause of cancer-related deaths among men. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 () performed as an oncogene in multiple cancers including PC. However, the molecular mechanisms of MALAT1 implicated in PC progression have not been thoroughly elaborated.

Materials And Methods: Reverse transcription-quantitative polymerase chain reaction assay was used to detect the expressions of MALAT1 and microRNA-1 (miR-1). Protein levels of cleaved poly (ADP-ribose) polymerase, cleaved caspase-3, BAX, bcl-2, and KRAS were determined using a western blot assay. Cell proliferation was assessed by colony formation and MTS assays. Cell migration capacity was examined by transwell migration assay (Corning Incorporated, Corning, NY, USA). Apoptosis rate was measured by flow cytometry via double staining of annexin V-FITC and propidium iodide. Luciferase and RNA immunoprecipitation assays were employed to explore the relationship among miR-1, MALAT1, and KRAS.

Results: MALAT1 expression was upregulated and miR-1 expression was downregulated in PC tissues and cell lines. MALAT1 knockdown inhibited cell proliferation and migration, and promoted cell apoptosis in androgen receptor-negative DU145 and PC3 cells. Molecular mechanism explorations disclosed that MALAT1 acted as a molecular sponge of miR-1 in DU145 cells. Moreover, miR-1 downregulation partly abrogated MALAT1 silencing-mediated anti-proliferative, antimigratory, and proapoptotic effects in DU145 and PC3 cells. Further investigation revealed that KRAS was a target of miR-1 in DU145 cells. MALAT1 acted as a competing endogenous RNA of miR-1, resulting in the increase of KRAS expression in DU145 and PC3 cells. Furthermore, miR-1 overexpression hampered proliferation and migration and promoted apoptosis in DU145 and PC3 cells, while these effects were markedly weakened following KRAS upregulation.

Conclusion: MALAT1 knockdown inhibited proliferation and migration and facilitated apoptosis by upregulating miR-1 and downregulating KRAS in androgen receptor-negative PCa cells, providing a new insight into the molecular basis of MALAT1 and a potential biomarker or therapeutic target for suppressing castration-resistant PC.

Citing Articles

Transcription factor STAT4 counteracts radiotherapy resistance in breast carcinoma cells by activating the MALAT1/miR-21-5p/THRB regulatory network.

Guo L, Ding G, Ba Y, Tan B, Tian L, Wang K Am J Cancer Res. 2024; 14(4):1501-1522.

PMID: 38726265 PMC: 11076251. DOI: 10.62347/VSJU7227.


NCAPD3 exerts tumor-promoting effects in prostatic cancer via dual impact on miR-30a-5p by STAT3-MALAT1 and MYC.

Zhang Y, Shao Y, Ren J, Fang Y, Yang B, Lu S Cell Death Discov. 2024; 10(1):159.

PMID: 38561330 PMC: 10985108. DOI: 10.1038/s41420-024-01930-7.


Structure-activity relationship study of mesyl and busyl phosphoramidate antisense oligonucleotides for unaided and PSMA-mediated uptake into prostate cancer cells.

Sergeeva O, Akhmetova E, Dukova S, Beloglazkina E, Uspenskaya A, Machulkin A Front Chem. 2024; 12:1342178.

PMID: 38501046 PMC: 10944894. DOI: 10.3389/fchem.2024.1342178.


Single cell-transcriptomic analysis informs the lncRNA landscape in metastatic castration resistant prostate cancer.

Saha D, Dang H, Zhang M, Quigley D, Feng F, Maher C NPJ Genom Med. 2024; 9(1):14.

PMID: 38396008 PMC: 10891057. DOI: 10.1038/s41525-024-00401-3.


n6-methyladenosine-modified circular RNA family with sequence similarity 126, member A affects cholesterol synthesis and malignant progression of prostate cancer cells by targeting microRNA-505-3p to mediate calnexin.

Luo L, Li P, Xie Q, Wu Y, Qin F, Liao D J Cancer. 2024; 15(4):966-980.

PMID: 38230215 PMC: 10788727. DOI: 10.7150/jca.89135.


References
1.
Taft R, Pang K, Mercer T, Dinger M, Mattick J . Non-coding RNAs: regulators of disease. J Pathol. 2009; 220(2):126-39. DOI: 10.1002/path.2638. View

2.
Lai M, Yang Z, Zhou L, Zhu Q, Xie H, Zhang F . Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2011; 29(3):1810-6. DOI: 10.1007/s12032-011-0004-z. View

3.
Kawakami K, Enokida H, Chiyomaru T, Tatarano S, Yoshino H, Kagara I . The functional significance of miR-1 and miR-133a in renal cell carcinoma. Eur J Cancer. 2011; 48(6):827-36. DOI: 10.1016/j.ejca.2011.06.030. View

4.
Tay Y, Rinn J, Pandolfi P . The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505(7483):344-52. PMC: 4113481. DOI: 10.1038/nature12986. View

5.
Liz J, Esteller M . lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta. 2015; 1859(1):169-76. DOI: 10.1016/j.bbagrm.2015.06.015. View